Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (Virtual Conference) Fall 2024

October 24, 2024 to October 26, 2024

- This conference will be a virtual (online) event. -

Overview

The demand for cancer care is expected to increase by 40% over the next six years; however, ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of all patients, advanced practice providers (APPs), whose education and training focus on health promotion, disease prevention, and primary care medical management, have been increasingly sought-after to fill this shortage. However, many new APPs have little background and training in oncology. As a result, oncology practices need to provide new staff with an onboarding program to help further their knowledge of hematology and oncology.

To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers.” In this two-and-a-half-day virtual program, clinicians will gain a greater understanding of cancer treatment, cancer therapies, side effects, supportive care strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment strategies for hematologic disorders and solid malignancies. Participation in the program will allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide APPs with a deeper understanding of the cancer treatment strategies they need to support and care for cancer patients as part of the multidisciplinary oncology care team.

This program is appropriate for nurse practitioners, physician assistants, nurses, and pharmacists in hematology/oncology seeking an in-depth review of cancer treatment strategies and therapies.

 

 Registration 

 Pricing

 Deadline

 Early Bird

 $100

 July 24, 2024

 Advanced 

 $125

 September 24, 2024

 General Registration

 $150

 October 24, 2024

 Student/Fellows*

 $25

 

 Industry Employee** registration is date based pricing +$300

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact info@horizoncme.com for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc). 

Learning Objectives.

  1. Outline strategies for the treatment of common solid and hematologic malignancies
  2. Summarize the role of genetics and molecular testing in cancer care 
  3. Implement palliative care and pain management strategies for patients with cancer
  4. Discuss strategies for the administration and management of chemotherapy
  5. Identify and appropriately manage immune-related adverse events
  6. Recognize and treat the adverse effects associated with radiation oncology

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By                                                        In Partnership with

                                                                  

Course summary
Available credit: 
  • 21.75 AMA PRA Category 1 Credit
    Horizon CME designates this Live activity for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 21.75 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 21.75 credit.
  • 4.75 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 4.75 credit.
Course opens: 
05/08/2024
Course expires: 
11/28/2024
Event starts: 
10/24/2024 - 8:00am PDT
Event ends: 
10/26/2024 - 12:35pm PDT
Cost:
$150.00
Rating: 
0

Commercial Support: Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (Virtual Conference) Fall 2024 is supported in part by independent medical educational grants from Merck Sharp & Dohme Corp LLC and Regeneron Pharmaceuticals, Inc.

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Eastern Standard Time Zone

Thursday, October 24, 2024 

11:00am Welcome, Introductions, & CE Housekeeping
11:15am(01) Biomarker Testing: Understanding The How, Benefits, and Translating to Patient Care
» Anthony J. Olszanski, RPh, MD - Vice-Chair, Department of Hematology/Oncology Director, Phase 1 Developmental Therapeutics Program Director, Medical Oncology Melanoma Program Fox Chase Cancer Center
11:45am (02) Patience and Understanding: Palliative Care for the APP
» Alicia M. Rigby, MSN, RN, APRN, AOCNP - Nurse Practitioner University of California, Davis
12:45pmStump the Faculty - Panel Q&A Discussion
1:00pmBreak
1:15pm (03) Pain Management: An Integral Component of Caring for the Oncology Patient
» Tanya Uritsky, PharmD, BCPP - Opioid Stewardship Coordinator University of Pennsylvania 
2:15pm (04) What is Chemotherapy
» Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP - Clinical Oncology Pharmacist University of Illinois College of Pharmacy
3:15pmStump the Faculty - Panel Q&A Discussion
3:30pmBreak
3:45pm (05) Treating Melanoma in 2024: The Age of Immunotherapy and Targeted Therapy
» Suzanne McGettigan, CRNP, ANP-BC, AOCN - Oncology Nurse Practitioner, Abramson Cancer Center Associate Director of Clinical Services, Tara Miller Melanoma Center University of Pennsylvania Health System
4:15pm (06) Identification and Management of Immune Related Adverse Events
» Marianne Davies, DNP, ACNP, AOCNP, FAAN - Associate Professor Yale University Yale School of Nursing Oncology Nurse Practitioner-Thoracic & Solid Tumor Senior Advanced Practice Provider II Smilow Cancer Hospital at Yale-New Haven Yale Comprehensive Cancer Center
4:45pm(07) Deciphering Radiation Oncology: A Deeper Dive into Acute and Late Effects from Treatment
» Bridgett Harr, CNP - Nurse Practitioner Cleveland Clinic
5:45pm Stump the Faculty - Panel Q&A Discussion
6:00pm Adjourn

Friday, October 25, 2024 

7:55am Welcome, Introductions, & CE Housekeeping
8:00am (08) Neuro-Oncology for the APP: What is Going on Up There?
» Vanessa Nevins, PA-C, RDMS, RT - Oncology Physician Assistant, Yale New Haven Smilow Cancer Hospital
8:30amStump the Faculty - Panel Q&A Discussion
8:45am (09) Breast Oncology: Awareness and Current Knowledge
» Kayla Freeman, DNP, APRN, FNP-C - Breast Oncology Nurse Practitiner, Emory Winship Cancer Institute
9:45am(10) Gastric Cancer: A Review of Current and Emerging Treatment Modalities
» Sujata Kane, MS, RD, PA-C - Physician Assistant Winship Cancer Institute, Emory University
10:15amStump the Faculty - Panel Q&A Discussion
10:30amBreak
10:45am (11) Lung Cancer: Updates and Advancements
» Beth Sandy, MSN, CRNP - Nurse Practitioner, Thoracic Medical Oncology Abramson Cancer Center, University of Pennsylvania
11:45am (12) Updates in Treating and Managing Patients with Prostate, Bladder and Renal Cell Carcinoma
» Greta Russler, MSN, FNP-BC - Nurse Practitioner, Medical Oncology Winship Cancer Institute of Emory University
» Laura S. Wood, RN, MSN, OCN - Cleveland Clinic
1:00pmStump the Faculty - Panel Q&A Discussion
1:15pm Lunch Break
1:45pm (13) Head and Neck Cancer: Diagnosis, Staging, and Management
» Kristin M. Daly, MSN, ANP-BC, AOCNP - Medical Oncology Siteman Cancer Center Washington University, St. Louis School of Medicine
2:45pm(14) Colorectal Cancer: Overview, Current Treatments, and Emerging Therapies
» Sujata Kane, MS, RD, PA-C - Physician Assistant Winship Cancer Institute, Emory University
3:45pm Break
4:00pm(15) Multidisciplinary Management of Hepatocellular Carcinoma and Pancreatic Adenocarcinoma: Medical and Surgical Perspectives
» Katie L. Green, CRNP, MSN - Nurse Practitioner, Medical Oncology Abramson Cancer Center, University of Pennsylvania
» Taylor Aldridge, MMS, PA-C - Physician Assistant, Division of Surgical Oncology, Hepatobiliary and Pancreatic Surgery Stanford University
5:00pm (16) Gynecologic Malignancies: Clinical Pearls
» Rachel Frankenthal, PA-C - Gynecologic Oncologic Physician Associate UCLA Health
5:30pmStump the Faculty - Panel Q&A Discussion
5:45pmAdjourn

Saturday, October 26, 2024

7:55am Welcome, Introductions, & CE Housekeeping
8:00am (17) A Deep Dive into Multiple Myeloma
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic
» Donna Catamero, ANP-BC, OCN, CCRC - Associate Director of Myeloma Research Icahn School of Medicine at Mount Sinai Hospital New York, NY
9:00amStump the Faculty - Panel Q&A Discussion
9:15am(18) Advances in CLL for the Clinical Oncology APP
» Lisa Nodzon PhD, APRN, AOCNP - Advanced Registered Nurse Practitioner Moffitt Cancer Center
9:45am(19) Follicular Lymphoma for the Clinical Oncology APP
» Amy Goodrich, RN, MSN, CRNP - Nurse Practitioner Johns Hopkins
10:15amStump the Faculty - Panel Q&A Discussion
10:30amBreak
10:50am(20) Understanding and Managing Acute Leukemia, Myelodysplastic Syndrome, and Myelofibrosis
» Jennie M. Goble, PA-C - Physician Assistant Mayo Clinic
11:50am Lunch Break
12:20pm (21) Benign Heme
» Peter Hakos, PA-C - Cleveland Clinic
» Lauren Imboden, PA-C - Atrium Health Wake Forest Baptist
1:20pm(22) An Update of Current Treatment Options for Patients with Diffuse Large B-Cell Lymphoma
» Amitkumar Mehta, MD - Associate Professor of Medicine, Director of Lymphoma, CAR-T Cell Therapy Program University of Alabama
2:20pm(23) Sexuality
» Anne Katz, PhD, RN, FAAN - AASECT-Certified Sexuality Counselor CancerCare Manitoba
3:20pmStump the Faculty - Panel Q&A Discussion
3:35pmAdjourn
Online - Virtual Event
United States

Available Credit

  • 21.75 AMA PRA Category 1 Credit
    Horizon CME designates this Live activity for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 21.75 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 21.75 credit.
  • 4.75 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 4.75 credit.

Price

Cost:
$150.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above


Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above

How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
To receive documentation of credit, participants must:

  1. Login to the educational portal

  2. Attend the educational activity

  3. Complete the post test and online evaluation form. 

  4. Attest to the number of hours in attendance in order to generate your certificate 

*Requests from learners to claim credit after the evaluation closes will not be granted